KR920702235A - 모든-시스-1,3,5-트리아미노-2,4,6-시클로헥산트리올 및 그 유도체와 방사능 금속이온의 착물에 대한 방사능 진단 목적과 종양치료를 위한 용도 및 방사능 진단 목적용과 종양치료용 시약의 제조를 위한 용도 - Google Patents

모든-시스-1,3,5-트리아미노-2,4,6-시클로헥산트리올 및 그 유도체와 방사능 금속이온의 착물에 대한 방사능 진단 목적과 종양치료를 위한 용도 및 방사능 진단 목적용과 종양치료용 시약의 제조를 위한 용도

Info

Publication number
KR920702235A
KR920702235A KR1019920701057A KR920701057A KR920702235A KR 920702235 A KR920702235 A KR 920702235A KR 1019920701057 A KR1019920701057 A KR 1019920701057A KR 920701057 A KR920701057 A KR 920701057A KR 920702235 A KR920702235 A KR 920702235A
Authority
KR
South Korea
Prior art keywords
alkyl group
use according
formula
radioactive metal
iib
Prior art date
Application number
KR1019920701057A
Other languages
English (en)
Korean (ko)
Inventor
에르니 이시도르
쉬나이더 발터
헤크게츠쉬바일러 카스파르
가이서 페터
Original Assignee
원본미기재
라보라토리엔 하우스만 아게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 원본미기재, 라보라토리엔 하우스만 아게 filed Critical 원본미기재
Publication of KR920702235A publication Critical patent/KR920702235A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0482—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group chelates from cyclic ligands, e.g. DOTA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
KR1019920701057A 1990-09-05 1991-09-05 모든-시스-1,3,5-트리아미노-2,4,6-시클로헥산트리올 및 그 유도체와 방사능 금속이온의 착물에 대한 방사능 진단 목적과 종양치료를 위한 용도 및 방사능 진단 목적용과 종양치료용 시약의 제조를 위한 용도 KR920702235A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4028139A DE4028139A1 (de) 1990-09-05 1990-09-05 Verwendung der komplexe radioaktiver metallionen mit all-cis-1,3,5-triamino-2,4,6-cyclohexantriol und seinen derivaten fuer roentgendiagnostische zwecke und in der tumortherapie sowie zur herstellung von mitteln fuer roentgendiagnostische zwecke und fuer die tumortherapie
DEP40281396 1990-09-05
PCT/EP1991/001679 WO1992004056A1 (de) 1990-09-05 1991-09-05 VERWENDUNG DER KOMPLEXE RADIOAKTIVER METALLIONEN MIT all-cis-1,3,5-TRIAMINO-2,4,6-CYCLOHEXANTRIOL UND SEINEN DERIVATEN FÜR RÖNTGENDIAGNOSTISCHE ZWECKE UND IN DER TUMORTHERAPIE SOWIE ZUR HERSTELLUNG VON MITTELN FÜR RÖNTGENDIAGNOSTISCHE ZWECKE UND FÜR DIE TUMORTHERAPIE

Publications (1)

Publication Number Publication Date
KR920702235A true KR920702235A (ko) 1992-09-03

Family

ID=6413642

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019920701057A KR920702235A (ko) 1990-09-05 1991-09-05 모든-시스-1,3,5-트리아미노-2,4,6-시클로헥산트리올 및 그 유도체와 방사능 금속이온의 착물에 대한 방사능 진단 목적과 종양치료를 위한 용도 및 방사능 진단 목적용과 종양치료용 시약의 제조를 위한 용도

Country Status (10)

Country Link
EP (1) EP0504339A1 (de)
JP (1) JPH05502456A (de)
KR (1) KR920702235A (de)
AU (1) AU658148B2 (de)
CA (1) CA2073050A1 (de)
DE (1) DE4028139A1 (de)
MX (1) MX9100967A (de)
PT (1) PT98869A (de)
TW (1) TW197951B (de)
WO (1) WO1992004056A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830430A (en) 1995-02-21 1998-11-03 Imarx Pharmaceutical Corp. Cationic lipids and the use thereof
CN104321082A (zh) * 2012-05-18 2015-01-28 拜耳医药股份有限公司 用于x射线成像的双氮杂肌醇重金属络合物
EP2796152A1 (de) 2013-04-25 2014-10-29 Bayer Pharma Aktiengesellschaft Unsymetrische Bis Azainositol Hafnium Komplexe zur Röntgendiagnostik
EP2873670A1 (de) 2013-11-14 2015-05-20 Bayer Pharma Aktiengesellschaft Bis Azainositolzirkoniumkomplexe zur Röntgendiagnostik

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3503614A1 (de) * 1985-02-02 1986-08-07 Laboratorien Hausmann AG, St. Gallen All-cis-1,3,5-triamino-2,4,6-cyclohexantriol-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate
GB8900719D0 (en) * 1989-01-13 1989-03-08 Nycomed As Compounds
CH679742A5 (de) * 1990-01-09 1992-04-15 Byk Gulden Lomberg Chem Fab

Also Published As

Publication number Publication date
AU8436791A (en) 1992-03-30
TW197951B (de) 1993-01-11
WO1992004056A1 (de) 1992-03-19
PT98869A (pt) 1992-07-31
DE4028139A1 (de) 1992-03-12
JPH05502456A (ja) 1993-04-28
EP0504339A1 (de) 1992-09-23
CA2073050A1 (en) 1992-03-06
MX9100967A (es) 1992-05-04
AU658148B2 (en) 1995-04-06

Similar Documents

Publication Publication Date Title
US4419339A (en) Formulation and method of making cationic lipophilic complexes
KR880012572A (ko) 질소함유 고리형 배위자의 제조방법
Cooper Crown thio ether chemistry
JPH04506955A (ja) 窒素含有マクロ環状リガンド及びそれらの金属複合体
KR910014377A (ko) 6-원 환을 함유하는 마크로사이클릭 테트라아자 화합물, 이의 제조방법 및 이를 함유하는 약제
AU587637B2 (en) Carboxy,carboalkoxy and carbamyl substituted isonitrile radionuclide complexes
US5380897A (en) Tri(platinum) complexes
US5409915A (en) Bis-platinum (IV) complexes as chemotherapeutic agents
KR920702235A (ko) 모든-시스-1,3,5-트리아미노-2,4,6-시클로헥산트리올 및 그 유도체와 방사능 금속이온의 착물에 대한 방사능 진단 목적과 종양치료를 위한 용도 및 방사능 진단 목적용과 종양치료용 시약의 제조를 위한 용도
EP0472665B1 (de) 99 m Tc (III) herzmuskelbildende Mittel, wirksam beim Menschen
Cramer et al. Crystal and molecular structure and isotropic hydrogen-1 nuclear magnetic resonance shifts of hexakis (acetic acid) nickel (II) tetrafluoroborate [Ni (AcOH) 6](BF4) 2
Holm et al. Nontemplate synthesis of an unsaturated tetraaza [14] macrocycle and its metal (II) complexes
KR960706467A (ko) 아릴 할라이드 치환된 금속 착물, 이를 함유하는 약제, 진단상의 그의 용도 및 이 착물 및 약제의 제조 방법(Aryl Halide Substituted Metallic Complexes, Pharmaceuticals Containing These Complexes, Their Use for Diagnostic Purposes, and Methods for Preparing the Complexes and Pharmaceuticals)
Okamoto et al. Preparation and Circular Dichroism of Six Isomers of Bis (l-alaninate-N-monoacetato) cobaltate (III) Complexes
KR860000871A (ko) 방사성 핵종의 부위강화 진달성 화합물 및 그 사용법
US4872561A (en) Carboxy, carboalkoxy and carbamile substituted isonitrile radionuclide complexes
US4921944A (en) Method of pharmaceutic production
EP0419538A4 (en) Technetium (iii/ii) imaging agents
KR890003788A (ko) 신규한 말로네이트 유도체의 수용성 백금복합체 및 그의 제조방법
KR870003129A (ko) 항 종양성 백금 착제의 제조방법
KR930007964A (ko) 저 산소 국재화 잔기를 함유하는 레늄 및 테크네륨 착물
KR870000935A (ko) 신규의 방사성 약 화합물 및 이 약화합물 제조용 킬레이트제
EP0138384B1 (de) Veranschaulichung von Herzinfarkten durch radioaktive Metalle komplexiert mit Phosphonat-Derivaten
ES394980A1 (es) Un procedimiento para la preparacion de nuevos benzopira- nos.
PL147612B1 (en) Method of obtaining a pharmaceutic with affinity to neoplastic tissues

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application